Dr. Matthew S. Logsdon, MD

Dr. Logsdon practices at Eccs at St Francis - HOPD in Colorado Springs, Colorado.

Dr. Logsdon's NPI, 1457336976, was assigned on December 7, 2005. Dr. Logsdon graduated from Baylor College Of Medicine in 1997. Dr. Logsdon holds Colorado license 42233.

Dr. Logsdon's primary practice is Eccs at St Francis - HOPD, at 6031 E Woodmen Rd, Colorado Springs, CO 80923.

Dr. Logsdon's primary practice is Eccs at St Francis - HOPD in Colorado Springs, Colorado. Dr. Logsdon is also affiliated with UCHealth Memorial Hospital Central. The medical group on file is Rocky Mountain Cancer Centers. Dmand AI also links Dr. Logsdon to 3 more hospitals, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Logsdon practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Logsdon's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Logsdon is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Logsdon's licenses on file in 3 states: Colorado, Texas and Tennessee.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Logsdon treats.

CMS data shows 33,524 Medicare services from Dr. Logsdon across 64 procedure codes in 2024, for 500 Medicare patients. Medicare paid $587,495 for them.

CMS counts 500 Medicare patients who saw Dr. Logsdon in 2024. The largest group is 65 to 74, with 243 patients. 66% of them have high cholesterol, and 65% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Logsdon's median patient age at 70, with 52% women.

In 2024, Dr. Logsdon wrote 798 Medicare Part D claims for 156 patients. 66% of them were for generic drugs. CMS names the drug for 592 of them, across 23 drugs with 11 or more claims each, at $1,698,976 in total drug cost. In 2023, CMS named 738 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 73 out of 100 for Dr. Logsdon for performance year 2024, reported through an alternative payment model (APM). Dr. Logsdon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Logsdon as offering telehealth.

CMS Open Payments shows 39 general payments to Dr. Logsdon from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. EMD Serono, Inc. paid the most, $10,452.

Dmand AI lists 2 awards for Dr. Logsdon, most recently Regional Top Doctor in 2014.

Dr. Logsdon graduated from Baylor College Of Medicine in 1997. Dr. Logsdon is a member of ASCO.

Dr. Logsdon is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.